"Cyclic N-Oxides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen.
Descriptor ID |
D003497
|
MeSH Number(s) |
D03.661.243
|
Concept/Terms |
Cyclic N-Oxides- Cyclic N-Oxides
- N-Oxides, Cyclic
- Cyclic N Oxides
- N Oxides, Cyclic
- Oxides, Cyclic N
- Heterocyclic N-Oxides
- Heterocyclic N Oxides
- N-Oxides, Heterocyclic
|
Below are MeSH descriptors whose meaning is more general than "Cyclic N-Oxides".
Below are MeSH descriptors whose meaning is more specific than "Cyclic N-Oxides".
This graph shows the total number of publications written about "Cyclic N-Oxides" by people in this website by year, and whether "Cyclic N-Oxides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2004 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclic N-Oxides" by people in Profiles.
-
Jang S, Lewis TS, Powers C, Khuchua Z, Baines CP, Wipf P, Javadov S. Elucidating Mitochondrial Electron Transport Chain Supercomplexes in the Heart During Ischemia-Reperfusion. Antioxid Redox Signal. 2017 07 01; 27(1):57-69.
-
Polyzos A, Holt A, Brown C, Cosme C, Wipf P, Gomez-Marin A, Castro MR, Ayala-Pe?a S, McMurray CT. Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes. Hum Mol Genet. 2016 05 01; 25(9):1792-802.
-
Javadov S, Jang S, Rodriguez-Reyes N, Rodriguez-Zayas AE, Soto Hernandez J, Krainz T, Wipf P, Frontera W. Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats. Oncotarget. 2015 Nov 24; 6(37):39469-81.
-
Budworth H, Harris FR, Williams P, Lee DY, Holt A, Pahnke J, Szczesny B, Acevedo-Torres K, Ayala-Pe?a S, McMurray CT. Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington's Disease. PLoS Genet. 2015 Aug; 11(8):e1005267.
-
Escobales N, Nu?ez RE, Jang S, Parodi-Rullan R, Ayala-Pe?a S, Sacher JR, Skoda EM, Wipf P, Frontera W, Javadov S. Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. J Mol Cell Cardiol. 2014 Dec; 77:136-46.
-
Roux B, Islam SM. Restrained-ensemble molecular dynamics simulations based on distance histograms from double electron-electron resonance spectroscopy. J Phys Chem B. 2013 May 02; 117(17):4733-9.
-
Xun Z, Rivera-S?nchez S, Ayala-Pe?a S, Lim J, Budworth H, Skoda EM, Robbins PD, Niedernhofer LJ, Wipf P, McMurray CT. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep. 2012 Nov 29; 2(5):1137-42.
-
Bayorh MA, Mann G, Walton M, Eatman D. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats. Clin Exp Hypertens. 2006 Feb; 28(2):121-32.
-
Lu N, Helwig BG, Fels RJ, Parimi S, Kenney MJ. Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II. Am J Physiol Heart Circ Physiol. 2004 Dec; 287(6):H2626-33.
-
Liang XJ, Yin JJ, Zhou JW, Wang PC, Taylor B, Cardarelli C, Kozar M, Forte R, Aszalos A, Gottesman MM. Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells. Exp Cell Res. 2004 Feb 15; 293(2):283-91.